Table 3 Relevant literature to costs and length of stays (LOS) of patients with lower respiratory tract infection
Author, Year | Study country | Study design | Adjusted for time – dependency bias | Type of infection | DRG-based | Exposed : unexposed | Attributable costs | Attributable hospital LOS |
|---|---|---|---|---|---|---|---|---|
Kollef, 2012 [6] | USA | Matched cohort, retrospectively | No | VAP | Yes | 2,144 : 2,144 | 39,828 USD* | 13 days* |
Restrepo, 2010 [7] | USA | Matched cohort, retrospectively | No | VAP | Yes | 30 : 90 | 35,480 USD* | 13 days* |
Cocanour, 2005 [5] | USA | Matched case control, prospectively | No | VAP | Yes | 70 : 70 | 57,158 USD*† | 14 days*† |
Warren, 2003 [8] | USA | Cohort study, prospectively | No | VAP | Yes | 127 : 629 | 11,897 USD | 21 days* |
This study, 2012 | Germany | Matched cohort, prospectively | Yes | LRTI | Yes | 49 : 49 | 23,651 USD | 9 days |